Cargando…

suPAR and Team Nephrology

Primary focal segmental glomerulosclerosis (FSGS) accounts for nearly 10 % of patients who require renal replacement therapy. Elevated circulating levels of soluble urokinase receptor (suPAR) have been identified as a biomarker to discriminate primary FSGS from other glomerulopathies. Subsequent rep...

Descripción completa

Detalles Bibliográficos
Autor principal: Trachtman, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026824/
https://www.ncbi.nlm.nih.gov/pubmed/24885021
http://dx.doi.org/10.1186/1741-7015-12-82

Ejemplares similares